Because the focus of this study was on the relationship between CTSC expression and the malignant phenotype and prognosis of glioma, the anti-tumor effects of the screened small-molecule compounds were not investigated in depth, but we believe our study will provide a new idea for drug development in glioma. Here, CTSC is linked to central nervous system cancer.